BioSpace News Archive

Genetown

ImmusanT Provides Year-End Update and Outlines Goals for 2018

ImmusanT today provided an update on accomplishments from 2017 and outlined goals for 2018.

January 4, 2018
·
5 min read
Drug Development

Tosk Reports Initiation of POC Human Studies

Tosk, Inc. reported today the completion of Phase 1 safety trials and the initiation of POC studies in human cancer patients for the prevention of mucositis side effects using its drug TK-90.

January 4, 2018
·
2 min read
Drug Development

Exelixis Announces Amendment to Clinical Research Protocol for Phase Ib Trial of Cabozantinib in Combination with Atezolizumab in Patients with Locally Advanced or Metastatic Solid Tumors

Exelixis today announced an amendment to the protocol for the phase 1b trial of cabozantinib in combination with atezolizumab (TECENTRIQ) in patients with locally advanced or metastatic solid tumors.

January 4, 2018
·
17 min read
German Biotech BioNTech Locks in $270M Series A

The Company previously completed a seed round fundraising in 2008 concurrent with its founding.

January 4, 2018
·
2 min read
Pharm Country

Amneal Biosciences Introduces Busulfan Injection, Generic for Busulfex

Amneal Biosciences has launched busulfan injection, the company’s AP-rated therapeutic equivalent for Busulfex 60 mg/10 mL.

January 4, 2018
·
1 min read
Bicycle Therapeutics Secures an Innovate UK Grant to Develop the Next Generation of Antibiotics

Bicycle Therapeutics announced today that it has been awarded a grant from Innovate UK, the UK’s innovation agency, to apply Bicycle technology to develop the next generation of novel antibiotics.

January 4, 2018
·
3 min read
Business

Effective April 1, 2018: OraSure CEO to Retire, New Leader Named

The Company also announced updated revenue guidance for the fourth quarter of 2017.

January 4, 2018
·
10 min read
Acasti Expands Global Patent Portfolio with Newly Granted Patents in South Korea and Canada

Acasti today announced the granting of a patent by the South Korean Patent Office and the granting of a corresponding patent by the Canadian Intellectual Property Office, further strengthening the international intellectual property position of CaPre.

January 4, 2018
·
4 min read
Policy

ISO 13485 Certification Achieved by Prime Technological Services

This internationally-accepted certification demonstrates Prime’s commitment to processes that meet the standards and compliance requirements within the medical device industry.

January 4, 2018
·
2 min read
Generex CEO Provides 2017 Year-End Summary to Stakeholders

This letter is being issued in advance of the Company’s investor conference call, to be hosted by Mr. Moscato, and his management team, today at 10:30 a.m. Eastern time:

January 4, 2018
·
18 min read